Details of the Drug Formulaction

General Information of Drug Formulation (ID: F24371)

• Formulation Name: Larotrectinib 25 mg capsule
• Company: Bayer Healthcare Pharmaceuticals ; Loxo Oncology

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Larotrectinib	(DM26CQR)	Solid tumour/cancer	2A00-2F9Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Gelatin	(E00630)	Not Available	Other agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent